Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$8.79 - $14.58 $53,961 - $89,506
-6,139 Reduced 3.71%
159,206 $1.5 Million
Q4 2022

Feb 09, 2023

SELL
$11.49 - $13.65 $23,600 - $28,037
-2,054 Reduced 1.23%
165,345 $2.02 Million
Q3 2022

Nov 14, 2022

SELL
$12.41 - $32.42 $315,362 - $823,857
-25,412 Reduced 13.18%
167,399 $2.08 Million
Q2 2022

Aug 12, 2022

BUY
$19.63 - $26.62 $413,878 - $561,256
21,084 Added 12.28%
192,811 $3.78 Million
Q1 2022

May 13, 2022

BUY
$24.65 - $29.0 $507,272 - $596,791
20,579 Added 13.62%
171,727 $4.48 Million
Q4 2021

Oct 18, 2022

SELL
$27.74 - $34.09 $23,329 - $28,669
-841 Reduced 0.55%
151,148 $4.29 Million
Q4 2021

Jan 18, 2022

SELL
$27.74 - $34.09 $23,329 - $28,669
-841 Reduced 0.55%
151,148 $4.29 Million
Q3 2021

Oct 18, 2022

BUY
$29.2 - $36.72 $266,450 - $335,070
9,125 Added 6.39%
151,989 $4.85 Million
Q3 2021

Nov 02, 2021

BUY
$29.2 - $36.72 $266,450 - $335,070
9,125 Added 6.39%
151,989 $4.85 Million
Q2 2021

Oct 18, 2022

SELL
$28.76 - $35.98 $1.44 Million - $1.8 Million
-49,947 Reduced 25.9%
142,864 $4.96 Million
Q1 2021

Oct 17, 2022

SELL
$27.85 - $34.49 $1.39 Million - $1.72 Million
-49,947 Reduced 25.9%
142,864 $4.21 Million
Q1 2021

Apr 13, 2021

BUY
$27.85 - $34.49 $299,554 - $370,974
10,756 Added 8.14%
142,864 $4.21 Million
Q4 2020

Jan 29, 2021

SELL
$27.53 - $33.79 $105,990 - $130,091
-3,850 Reduced 2.83%
132,108 $4.05 Million
Q3 2020

Nov 04, 2020

SELL
$21.1 - $29.13 $4.59 Million - $6.33 Million
-217,410 Reduced 61.53%
135,958 $3.64 Million
Q2 2020

Jul 31, 2020

SELL
$18.94 - $24.93 $14,716 - $19,370
-777 Reduced 0.22%
353,368 $7.41 Million
Q1 2020

May 01, 2020

BUY
$16.68 - $32.25 $178,309 - $344,752
10,690 Added 3.11%
354,145 $8 Million
Q4 2019

Feb 05, 2020

BUY
$25.29 - $29.45 $113,830 - $132,554
4,501 Added 1.33%
343,455 $10.1 Million
Q3 2019

Nov 12, 2019

BUY
$25.62 - $34.96 $630,456 - $860,295
24,608 Added 7.83%
338,954 $8.95 Million
Q2 2019

Jul 31, 2019

SELL
$31.11 - $34.79 $279,461 - $312,518
-8,983 Reduced 2.78%
314,346 $10.6 Million
Q1 2019

Apr 30, 2019

BUY
$29.0 - $32.83 $9.38 Million - $10.6 Million
323,329 New
323,329 $0

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Royal London Asset Management LTD Portfolio

Follow Royal London Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.